Investors should be thankful that Recell Go caused bleh upside SP movement. —Gives them more time to load up before Recell Go demonstrates what it can do in the next earnings report. If earnings look healed, RCEL could reach $30 in a short time. So the focus of Avita should be to reach the low end of annual guidance and to make sure guidance for profitability by Q3 ‘25 remains intact.
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-35
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
-0.145(5.31%) |
Mkt cap ! $175.6M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.54 | $890.5K | 346.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 5290 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 15577 | 12 |
View Market Depth
| Last trade - 15.13pm 05/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |